Matches in Nanopublications for { ?s ?p "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP247018.RAzgGDUv88tjcrlZWG0NTFk7VSeArzPFsb3F2-7k0en-w130_assertion description "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247018.RAzgGDUv88tjcrlZWG0NTFk7VSeArzPFsb3F2-7k0en-w130_provenance.
- NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_assertion description "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_provenance.
- NP711469.RAUwwUh2VsrLR02PEMutCmdgl6xRdxI43v87lS6ayx1WA130_assertion description "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711469.RAUwwUh2VsrLR02PEMutCmdgl6xRdxI43v87lS6ayx1WA130_provenance.
- assertion description "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_assertion description "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_provenance.
- NP350337.RA-Urc9XA3ubuiVM8_OSjO1uVZTGh9SWTtZuMuHkpHarE130_assertion description "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350337.RA-Urc9XA3ubuiVM8_OSjO1uVZTGh9SWTtZuMuHkpHarE130_provenance.